Register
Login:
Share:
Email Facebook Twitter


VIDEO EXCLUSIVE: TSX-listed Transglobe Energy Corporation considers London listing


Sareum Share Chat (SAR)



Share Price: 0.85Bid: 0.80Ask: 0.90Change: 0.00 (0.00%)No Movement on Sareum
Spread: 0.10Spread as %: 12.50%Open: 0.85High: 0.85Low: 0.825Yesterday’s Close: 0.85


Share Discussion for Sareum


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


rata
Posts: 270
Off Topic
Opinion:No Opinion
Price:0.85
1 p
Wed 20:48
Long go soon, this is a mad price
 
Utahsaints
Posts: 924
Off Topic
Opinion:No Opinion
Price:0.85
RE: And we still have
Wed 19:53
October can't come soon enough, I need one of my shares to start moving up! It's be a very inactive period. I notice that sierra is not budging either
potnak
Posts: 702
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.825
View Thread (2)
RE: And we still have
Wed 13:45
Personally, I find anything CHK1 related a bit pointless now. I try not to waste time on it. The deal has been done and we just have to wait until the milestones start coming. There is literally nothing else we can do so why waste time speculating or constantly checking the SRRA price?

I would, however, like some news and a roadmap for the other compounds and I think that will kick off in October.
JonTangle
Posts: 442
Off Topic
Opinion:No Opinion
Price:0.825
View Thread (5)
RE: And we still have
Wed 13:26
Blimey.

So you complain when they notify you and update via RNS etc and moan when they don't?

What do you want the PR company to do? Buy all your shares for £1 each? LOL

No point in trying to force news that isn't there. It'll land when it lands, nothing anyone says on here is going to change things.
Aberystwyth
Posts: 267
Off Topic
Opinion:No Opinion
Price:0.825
And we still have
Wed 13:22
**** PR and the seller back to keep the price down

Lovely
Obelix
Posts: 10,674
Off Topic
Opinion:Buy
Price:0.825
Sierra Oncology
Wed 12:50
Looks like they are very busy at the moment, really good PR and trying to promote their business (Win situation there)
peterraf
Posts: 392
Off Topic
Opinion:No Opinion
Price:0.825
Sierra RNS
Wed 12:40
Sierra Oncology to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
Obelix
Posts: 10,674
Off Topic
Opinion:No Opinion
Price:0.85
RE: obelix
Wed 12:06
Thanks Thoth, it's really complicate if don't understand the process (like me for example). I just hope We get a deal for the others compounds that We've in our portfolio.
Do you think it's possible for Sierra to Buyout our Chk2 for certain amount instead of paying us royalties after they spend a lot? It's makes sense to me, Buy and don't pay anymore, than pay us a milestone every time We progress in the trial? Could be cheaper Buy now at P1 than pay a higher price when Chk2 progress
Malenko
Posts: 77
Off Topic
Opinion:No Opinion
Price:0.85
RE: So why the RNS
Wed 11:57
I don't see that they got anything wrong IMO.

The last RNS from SAR only seems pointless to us because we already know SRRA have posted the same news.

The news SRRA released has no mention of SAR that I can see.
Those who cared to dig a little deeper would have found the connection, but how many would bother to do that ?

Not so long ago we were complaining of a total lack of news, now we have two releases and complain it's pointless.




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.